1. Home
  2. LGCB vs SABS Comparison

LGCB vs SABS Comparison

Compare LGCB & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGCB
  • SABS
  • Stock Information
  • Founded
  • LGCB 2011
  • SABS 2014
  • Country
  • LGCB Japan
  • SABS United States
  • Employees
  • LGCB N/A
  • SABS N/A
  • Industry
  • LGCB
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGCB
  • SABS Health Care
  • Exchange
  • LGCB Nasdaq
  • SABS Nasdaq
  • Market Cap
  • LGCB 16.7M
  • SABS 15.8M
  • IPO Year
  • LGCB 2023
  • SABS N/A
  • Fundamental
  • Price
  • LGCB $2.54
  • SABS $2.15
  • Analyst Decision
  • LGCB
  • SABS Strong Buy
  • Analyst Count
  • LGCB 0
  • SABS 4
  • Target Price
  • LGCB N/A
  • SABS $9.50
  • AVG Volume (30 Days)
  • LGCB 5.5K
  • SABS 84.7K
  • Earning Date
  • LGCB 07-03-2025
  • SABS 11-05-2025
  • Dividend Yield
  • LGCB N/A
  • SABS N/A
  • EPS Growth
  • LGCB N/A
  • SABS N/A
  • EPS
  • LGCB N/A
  • SABS N/A
  • Revenue
  • LGCB $8,993,265.00
  • SABS $114,698.00
  • Revenue This Year
  • LGCB N/A
  • SABS N/A
  • Revenue Next Year
  • LGCB N/A
  • SABS N/A
  • P/E Ratio
  • LGCB N/A
  • SABS N/A
  • Revenue Growth
  • LGCB 5.80
  • SABS N/A
  • 52 Week Low
  • LGCB $1.22
  • SABS $1.00
  • 52 Week High
  • LGCB $13.70
  • SABS $6.60
  • Technical
  • Relative Strength Index (RSI)
  • LGCB 62.19
  • SABS 49.13
  • Support Level
  • LGCB $2.21
  • SABS $2.03
  • Resistance Level
  • LGCB $2.26
  • SABS $2.18
  • Average True Range (ATR)
  • LGCB 0.07
  • SABS 0.10
  • MACD
  • LGCB 0.04
  • SABS -0.00
  • Stochastic Oscillator
  • LGCB 100.00
  • SABS 38.71

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: